Trademark Overview
On Tuesday, May 3, 2022, a trademark application was filed for TETRA BIO-PHARMA with the United States Patent and Trademark Office. The USPTO has given the TETRA BIO-PHARMA trademark a serial number of 97392917. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, June 9, 2023. This trademark is owned by TETRA-BIO-PHARMA INC.. The TETRA BIO-PHARMA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Pharmaceutical preparations to treat medical conditions, namely, to treat anorexia, anxiety and depression, arthritis, rheumatoid arthritis, chronic pain, fibromyalgia, pain management in oncology, glaucoma, inflammation, insomnia and sleep disorders, Alzheimer's disease, Crohn's disease, nausea and vomiting, weight gain, ulcerative colitis, multiple sclerosis, amyotrophic lateral sclerosis, stress, irritable bowel syndrome, movement disorders, musculoskeletal disorders, Parkinson's disease, epilepsy
Medical devices for administering pharmaceutical preparations, namely, inhalers, masks, pipes, for administering pharmaceutical preparations by inhalation, to treat medical conditions, namely, to treat anorexia, anxiety and depression, arthritis, rheumatoid arthritis, chronic pain, fibromyalgia, pain management in oncology, glaucoma, inflammation, insomnia and sleep disorders, Alzheimer's disease, Crohn's disease, nausea and vomiting, weight gain, ulcerative colitis, multiple sclerosis, amyotrophic lateral sclerosis, stress, irritable bowel syndrome, movement disorders, musculoskeletal disorders, Parkinson's disease, epilepsy